XML 50 R19.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Share-Based Compensation (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2014
Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Options Outstanding | A summary of the stock option activity under the Company’s plans for the nine months ended March 31, 2014 is as follows:
|  |  |  |  | Weighted |
|  | Number |  |  | average |
|  | of |  |  | exercise |
|  | shares |  |  | price |
Options outstanding at June 30, 2013 |  |  | 14,434,970 |  |  | $ | 21.75 |
Options granted |  |  | 3,308,553 |  |  |  | 26.48 |
Less: |  |  |  |  |  |  |  |
Options exercised |  |  | 2,404,256 |  |  |  | 18.81 |
Options canceled or expired |  |  | 383,173 |  |  |  | 24.40 |
Options outstanding at March 31, 2014 |  |  | 14,956,094 |  |  | $ | 23.20 |
Schedule of Share-Based Compensation Recognized in Consolidated Statements of Comprehensive Income | Share-based compensation expense recognized and included in the condensed consolidated statements of income was allocated as follows:
|  | Three months ended |  |  | Nine months ended |
|  | March 31, |  |  | March 31, |
(In thousands) |  | 2014 |  |  | 2013 |  |  | 2014 |  |  | 2013 |
Cost of molecular diagnostic testing |  | $ | 207 |  |  | $ | 252 |  |  | $ | 639 |  |  | $ | 811 |
Cost of companion diagnostic services |  |  | 75 |  |  |  | 54 |  |  |  | 212 |  |  |  | 159 |
Research and development expense |  |  | 3,042 |  |  |  | 818 |  |  |  | 4,670 |  |  |  | 2,496 |
Selling, general, and administrative expense |  |  | 10,316 |  |  |  | 5,607 |  |  |  | 21,911 |  |  |  | 16,969 |
Total share-based compensation expense |  | $ | 13,640 |  |  | $ | 6,731 |  |  | $ | 27,432 |  |  | $ | 20,435 |

X
- Definition Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the following for fully vested share options (or share units) and share options expected to vest at the date of the latest statement of financial position: the number, weighted-average exercise price (or conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term of options (or share units) outstanding. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration